Improving cancer treatment and care through leadership and planning
Official title: Leadership, Planning and Evaluation
Funded at University of Rochester · NIH-11014534 · Data updated 2026-11-12
This study is all about making cancer treatment better at the Wilmot Cancer Institute by helping the team work together more effectively, so patients can look forward to improved care and support during their journey.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $319,829 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014534 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with cancer who are seeking innovative treatment options and support.
✕Less likely to help
Patients with non-cancerous conditions or those not seeking treatment at the Wilmot Cancer Institute may not benefit from this research.
What this research studies
This research focuses on enhancing the quality of cancer treatment and care at the Wilmot Cancer Institute by fostering collaboration among its leadership team. The project aims to implement strategic planning and evaluation processes that ensure effective communication and resource allocation for cancer research and patient care. By engaging with community outreach and mentoring programs, the institute seeks to improve patient outcomes and advance cancer research initiatives. Patients can expect a more coordinated approach to their care as a result of these efforts.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment protocols and better patient care experiences.
How similar studies have gone: Other cancer centers have successfully implemented similar leadership and planning initiatives, demonstrating the potential for improved patient outcomes.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Friedberg, Jonathan W — University of Rochester
- Study coordinator: Friedberg, Jonathan W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.